Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA3 | P07451 | 1/20 | 0.35 |
| ▸ | CA4 | P22748 | 1/20 | 0.35 |
| ▸ | CA6 | P23280 | 1/20 | 0.35 |
| ▸ | CA5A | P35218 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.35 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.35 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.34 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propionic Acid SCHEMBL1518988 | 0.77 | FFAR3 (0.48) | LMNACA12CA1CA2CA3 | |
| SCHEMBL15717118 | 0.76 | OR51E2 (0.53) | GPR84FFAR1OR51E2SMN1; SMN2TET2 | |
| SCHEMBL6963 | 0.76 | — | — | |
| SCHEMBL193026 | 0.76 | — | — | |
| SCHEMBL15355768 | 0.76 | — | — | |
| SCHEMBL264859 | 0.76 | — | — | |
| Alcohol SCHEMBL20856433 | 0.74 | ALDH1A1 (0.33) | LMNACA12CA1CA2CA3 | |
| Acetic Acid SCHEMBL482738 | 0.74 | FFAR3 (0.39) | CA12CA1CA9ALDH1A1PKM | |
| Acetic Acid SCHEMBL21834859 | 0.74 | FFAR3 (0.39) | CA12CA1CA9ALDH1A1PKM | |
| SCHEMBL1906466 | 0.74 | MEN1 (0.34) | CA12CA1CA9ALDH1A1PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110282464-A1 | Reactive Surgical Implants | SOFRADIM PRODUCTION (FR) | 2011-11-17 | — | — | US | claimed |
| EP-2444075-B1 | Self-supporting films for delivery of therapeutic agents | COVIDIEN LP (US) | 2018-09-05 | — | — | EP | disclosed |
| US-9861590-B2 | Self-supporting films for delivery of therapeutic agents | COVIDIEN LP (US) | 2018-01-09 | — | — | US | disclosed |
| EP-2444073-B1 | Methods of forming self-supporting films for delivery of therapeutics agents | COVIDIEN LP (US) | 2017-05-10 | — | — | EP | disclosed |
| EP-2570441-B1 | Bioabsorbable surgical composition | COVIDIEN LP (US) | 2015-04-01 | — | — | EP | disclosed |
| US-8920867-B2 | Methods of forming self-supporting films for delivery of therapeutic agents | COVIDIEN LP (US) | 2014-12-30 | — | — | US | disclosed |
| EP-2719717-A1 | Compositions and methods of forming films for improved drug delivery | Covidien LP (US) | 2014-04-16 | — | — | EP | disclosed |
| US-8632839-B2 | Methods of forming self-supporting films for delivery of therapeutic agents | COVIDIEN LP (US) | 2014-01-21 | — | — | US | disclosed |
| EP-2111877-B1 | Bioabsorbable surgical composition | COVIDIEN LP (US) | 2013-09-18 | — | — | EP | disclosed |
| EP-2177552-B1 | Bioabsorbable surgical composition | COVIDIEN LP (US) | 2013-03-27 | — | — | EP | disclosed |
| US-20120094004-A1 | Methods of Forming Self-Supporting Films for Delivery of Therapeutic Agents | COVIDIEN LP | 2012-04-19 | — | — | US | disclosed |
| US-20120095418-A1 | Self-Supporting Films For Delivery Of Therapeutic Agents | COVIDIEN LP | 2012-04-19 | — | — | US | disclosed |
| US-20120094005-A1 | Methods of Forming Self-Supporting Films for Delivery of Therapeutic Agents | COVIDIEN LP | 2012-04-19 | — | — | US | disclosed |
| EP-2425828-A2 | Films for delivery of a therapeutic agent | Tyco Healthcare Group LP (US) | 2012-03-07 | — | — | EP | disclosed |
| US-20120009240-A1 | Films for Delivery of a Therapeutic Agent | COVIDIEN LP | 2012-01-12 | — | — | US | disclosed |
| US-20110282464-A1 | Reactive Surgical Implants | SOFRADIM PRODUCTION (FR) | 2011-11-17 | — | — | US | disclosed |
| EP-2177552-A1 | Bioabsorbable surgical composition | Tyco Healthcare Group LP (US) | 2010-04-21 | — | — | EP | disclosed |
| US-20100092533-A1 | Bioabsorbable Surgical Composition | COVIDIEN LP | 2010-04-15 | — | — | US | disclosed |
| US-20090266467-A1 | Bioabsorbable Surgical Composition | TYCO HEALTHCARE GROUP LP | 2009-10-29 | — | — | US | disclosed |
| EP-2111877-A1 | Bioabsorbable surgical composition | Tyco Healthcare Group LP (US) | 2009-10-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110282464-A1 | Reactive Surgical Implants | CYBB, F2RL3, MACF1 | LMNA 4821/4885CA12 821/4885CA1 981/4885 |
| US-20100092533-A1 | Bioabsorbable Surgical Composition | CD44, EPCAM, CD68 | LMNA 3828/4885CA12 64/4885CA1 71/4885 |
| US-20090266467-A1 | Bioabsorbable Surgical Composition | EPCAM, FABP2, CD68 | LMNA 2720/4885CA12 2089/4885CA1 2269/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.